SALVATORE MILAZZO: Open Payments
NPI 1619500063 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,983 in 106 payments from 19 companies in 2025. Trend: 2023 $1,001 · 2024 $1,132 · 2025 $2,983
Food & beverage: $2,872Education: $111
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $412 |
| ABBVIE INC. | 12 | $289 |
| Botanix SB Inc | 11 | $265 |
| GENZYME CORPORATION | 8 | $265 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $232 |
| Amgen Inc. | 8 | $215 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $213 |
| Arcutis Biotherapeutics, Inc. | 14 | $198 |
| Regeneron Healthcare Solutions, Inc. | 5 | $172 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
Products named: DUPIXENT, CIBINQO, SOFDRA, Otezla, Cabtreo, Zoryve, RINVOQ, SKYRIZI.
Industry payments across NY — which companies pay providers there.
